Bronchiectasis in Infants and Preschool Children Diagnosed with Cystic Fibrosis after Newborn Screening-Reference-Cited by-同舟云学术

Bronchiectasis in Infants and Preschool Children Diagnosed with Cystic Fibrosis after Newborn Screening

Published:2009-11 Issue:5 Volume:155 Page:623-628.e1
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Stick Stephen M.,Brennan Siobhain,Murray Conor,Douglas Tonia,von Ungern-Sternberg Britta S.,Garratt Luke W.,Gangell Catherine L.,De Klerk Nicholas,Linnane Barry,Ranganathan Sarath,Robinson Phillip,Robertson Colin,Sly Peter D.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference32 articles.

1. Cystic Fibrosis Foundation. Newborn screening. [Website]. Maryland: Cystic Fibrosis Foundation. [updated 2007 Feb 07; cited 2008 April 24]; Available from: http://www.cff.org/AboutCF/Testing/NewbornScreening/

2. Pulmonary complications in adult patients with cystic fibrosis;Stenbit;Am J Med Sci,2008

3. Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis;Twiss;Thorax,2006

4. Changes in airway dimensions on computed tomography scans of children with cystic fibrosis;de Jong;Am J Respir Crit Care Med,2005

5. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis;de Jong;Eur Respir J,2004

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis;Nature Reviews Disease Primers;2024-08-08

2. Comparative sensitivity of early cystic fibrosis lung disease detection tools in school aged children;Journal of Cystic Fibrosis;2024-07

3. Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6‐11 years with cystic fibrosis in a real‐world setting;Pediatric Pulmonology;2024-06-13

4. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians;Current Problems in Pediatric and Adolescent Health Care;2024-06

5. Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study;Journal of Cystic Fibrosis;2024-05